The Oren Miller Dad 2.0 Scholarship Fund

In our fourth year, we were honored to rename our scholarship fund after Oren Miller, a beloved and revered dad blogger and friend who died of lung cancer on February 28, 2015.

We created this fund so that those who have received much from their Dad 2.0 Summit experiences can literally “pay it forward,” providing assistance to first-time attendees with financial needs. Each designee receives a $500 “Miller Grant” to help offset travel and lodging costs, as well as a free conference ticket.

In just four years, our generous community has helped 51 dads attend a Dad 2.0 Summit!

 

DONATE TO THE FUND

This year’s scholarship donations are being made through Fundly.com. Upon purchasing a ticket to Dad 2.0 Summit, you’ll be prompted to make a contribution, or you can head straight to the fundraising page

Contribution deadline is Friday, November 30. Every little bit helps!

 

 

 

APPLY FOR A SCHOLARSHIP

To apply for a Miller Grant, fill out the form below. The application deadline is Friday, November 30. Dad 2.0 leadership and the scholarship chair review the applications. Final recipients will be announced on Friday, December 7.

More about Oren Miller

Other than his family, Oren Miller’s greatest passion was ensuring that every father’s voice is heard, regardless of their platform, popularity, or audience size.

In 2013, Oren took his passion for community one step further by starting the Dad Bloggers Facebook group. The group served to connect many of the dads Oren had met online, and quickly evolved beyond its more practical purposes of discussing blogging and social media to a place where fathers could find and provide parenting advice, emotional support, and genuine friendship.

The group functions in tandem with Dad 2.0, serving as a place to continue in-person conversations and relationships begun at the Summits, as well as generate interest and excitement for new attendees.

Visit A Blogger and a Father to read Oren’s writing on fatherhood, family, and his battle with cancer.